The White House spent Saturday celebrating a Washington Post headline that declared the sharpest drop in prescription drug prices in more than 60 years. The message was clear: President Donald Trump deserves the credit. But here's the twist: the very article being touted quotes experts who say the real driver is a law signed by his predecessor.

According to Consumer Price Index data from the Bureau of Labor Statistics, prescription drug prices fell 3.1% in July, the steepest year-over-year decline in more than six decades. That's a big number, and the administration is eager to claim it.

Experts Point to Biden-Era Law, Not Trump Policy

Independent experts cited by the Washington Post said the drop is more likely tied to Medicare drug-price negotiations required under Joe Biden's 2022 Inflation Reduction Act than to any Trump administration policy.

Richard Frank, a professor emeritus of health economics at Harvard University, told the Post that if he had to bet on the cause, "it would be probably stuff around the Inflation Reduction Act." The law lowers prescription drug costs for people with Medicare. Frank added that Trump's efforts "wouldn't be where I'd place my money."

Vanderbilt's Stacie Dusetzina agreed, noting the 10 drugs already negotiated under the law are widely used and "would likely be reflected in the prescription drug index."

Trump Promotes Drug-Price Headline

President Trump held up the headline for cameras on Friday, declaring, "I told you that was going to happen."

On its official social media accounts, the White House's official caption read, "POV: you bring the receipts." Press Secretary Karoline Leavitt also shared the image.

White House Communications Director Steven Cheung had posted a screenshot of the headline on X on Thursday, the same day the article was published. He wrote, "All thanks to President Trump!" but did not link to the article.

So, is this a case of correlation being mistaken for causation? The data is real, but the story behind it is more nuanced than a simple victory lap. The Inflation Reduction Act's Medicare negotiations were designed to take effect over time, and the timing aligns with the price drop. Trump's own policies, like Most-Favored-Nation pricing and TrumpRX, may have had some impact, but experts aren't convinced they're the main driver.

For investors, this is a reminder that policy impacts can be complex and delayed. The drug pricing landscape is shifting, and understanding the underlying causes of price movements is crucial for making informed decisions.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by MarketDash editors.